FDA NDC Directory · JSON-LD · Markdown

RIVFLOZA

NDC 0169-5306 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namenedosiran
Labeler / ManufacturerNovo Nordisk
Marketing categoryNew Drug Application (innovator) · App NDA215842
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsNEDOSIRAN SODIUM (160 mg/mL)
Marketing started20240219
Package count1

External sources

Source: openFDA. Public-domain (CC0).